Ad is loading...
GSVPX
Price
$17.49
Change
-$0.17 (-0.96%)
Updated
Nov 15 closing price
VEXAX
Price
$146.43
Change
-$1.91 (-1.29%)
Updated
Nov 15 closing price
Ad is loading...

GSVPX vs VEXAX

Header iconGSVPX vs VEXAX Comparison
Open Charts GSVPX vs VEXAXBanner chart's image
Goldman Sachs Small/Mid Cap Value P
Price$17.49
Change-$0.17 (-0.96%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Admiral
Price$146.43
Change-$1.91 (-1.29%)
VolumeN/A
CapitalizationN/A
GSVPX vs VEXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVPX vs. VEXAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVPX is a StrongSell and VEXAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 107B vs. GSVPX (152M). VEXAX pays higher dividends than GSVPX: VEXAX (1.20) vs GSVPX (0.87). GSVPX was incepted earlier than VEXAX: GSVPX (7 years) vs VEXAX (24 years). GSVPX is a more actively managed with annual turnover of: 56.00 vs. VEXAX (11.00). GSVPX has a lower initial minimum investment than VEXAX: GSVPX (0) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 33.93 vs. GSVPX (27.59). VEXAX return over 5 years is better than : 60.98 vs. GSVPX (39.75).
GSVPXVEXAXGSVPX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years24 years-
Gain YTD14.76417.69983%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets152M107B0%
Annual Yield % from dividends0.871.2073%
Returns for 1 year27.5933.9381%
Returns for 3 years-5.57-2.32240%
Returns for 5 years39.7560.9865%
Returns for 10 yearsN/A131.61-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEC14.350.20
+1.41%
Diversified Energy Company plc
CVNA241.000.56
+0.23%
Carvana Co
FA17.50-0.35
-1.96%
First Advantage Corp
TTNP3.81-0.19
-4.64%
Titan Pharmaceuticals
INMB4.95-0.48
-8.92%
INmune Bio